Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK | PLOS ONE
![Myasthenia gravis, castleman disease, pemphigus, and anti‐phospholipid syndrome - Jakubíková - 2013 - Muscle & Nerve - Wiley Online Library Myasthenia gravis, castleman disease, pemphigus, and anti‐phospholipid syndrome - Jakubíková - 2013 - Muscle & Nerve - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/edf89891-c1cf-4657-925b-26c948b12cbf/mus23657-fig-0002-m.jpg)
Myasthenia gravis, castleman disease, pemphigus, and anti‐phospholipid syndrome - Jakubíková - 2013 - Muscle & Nerve - Wiley Online Library
![Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets - ScienceDirect Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572821003143-ga1.jpg)
Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets - ScienceDirect
![Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology](https://www.thelancet.com/cms/attachment/4528bbae-a780-434c-942e-17e63964c626/gr2_lrg.jpg)
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology
![Frontiers | Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies Frontiers | Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies](https://www.frontiersin.org/files/Articles/596621/fneur-11-596621-HTML/image_m/fneur-11-596621-g001.jpg)
Frontiers | Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies
![B cells in the pathophysiology of myasthenia gravis - Yi - 2018 - Muscle & Nerve - Wiley Online Library B cells in the pathophysiology of myasthenia gravis - Yi - 2018 - Muscle & Nerve - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c9acf5e0-20ae-4561-9031-a97b469d4ad3/mus25973-fig-0001-m.jpg)
B cells in the pathophysiology of myasthenia gravis - Yi - 2018 - Muscle & Nerve - Wiley Online Library
![Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology](https://www.thelancet.com/cms/attachment/5a1af1a5-7f6e-47d1-8b01-179f5e88c563/gr1_lrg.jpg)
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology
![Roles of cytokines and T cells in the pathogenesis of myasthenia gravis - Uzawa - 2021 - Clinical & Experimental Immunology - Wiley Online Library Roles of cytokines and T cells in the pathogenesis of myasthenia gravis - Uzawa - 2021 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/362eaee5-828f-4367-8a49-045bb699b4cd/cei13546-toc-0001-m.jpg?trick=1677211774914)
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis - Uzawa - 2021 - Clinical & Experimental Immunology - Wiley Online Library
![Biomedicines | Free Full-Text | Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis Biomedicines | Free Full-Text | Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis](https://www.mdpi.com/biomedicines/biomedicines-11-00449/article_deploy/html/images/biomedicines-11-00449-g001.png)